HilleVax | 8-K: Current report
HilleVax | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%), etc.
HilleVax | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Management Company, L.P.(3.78%),Deerfield Mgmt V, L.P.(3.78%), etc.
HilleVax | 10-Q: Q3 2024 Earnings Report
HilleVax | 8-K: HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
HilleVax | 8-K: Current report
HilleVax | 10-Q: Q2 2024 Earnings Report
HilleVax | 8-K: HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
HilleVax | 8-K: Current report
HilleVax | 8-K: Current report
HilleVax | SC 13G: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL PARTNERS, LP(9.5%),Tang Capital Management, LLC(9.5%), etc.
HilleVax | 8-K: Current report
HilleVax | 8-K: Current report
HilleVax | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner Frazier Life Sciences X, L.P.
HilleVax | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Patrick J. Heron(21.4%),James N. Topper(21.3%), etc.
HilleVax | 4: Statement of changes in beneficial ownership of securities-Director Kohli Aditya
HilleVax | EFFECT: Others
HilleVax | 8-K: HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
HilleVax | 10-Q: Q1 2024 Earnings Report
HilleVax | CORRESP: CORRESP